$10.84
-0.44-3.90%
At close: -
$10.84
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest Inhibrx Biosciences Stock News | NASDAQ:INBX | Benzinga
Get the latest news on Inhibrx Biosciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Inhibrx Biosciences performance
Categories: All
Wednesday, May 14, 2025
Tuesday, April 01, 2025
Tuesday, March 18, 2025
Monday, March 17, 2025
Wednesday, January 22, 2025
Tuesday, January 21, 2025
Thursday, November 14, 2024
Monday, November 04, 2024
Tuesday, September 03, 2024
Tuesday, August 27, 2024
Wednesday, August 14, 2024
Tuesday, July 23, 2024
Friday, June 07, 2024
Wednesday, June 05, 2024
Friday, May 31, 2024
Friday, May 24, 2024
Wednesday, February 28, 2024
Tuesday, January 23, 2024
- Inhibrx shares are trading higher after the c...
- French Drugmaker Sanofi Agrees To Buy Inhibrx's Candidate For Rare Genetic Indication, For About $2.2B
- Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project
- JMP Securities Downgrades Inhibrx to Market P...
- Inhibrx Sells INBRX-101 To Sanofi For Up To $...
Monday, November 20, 2023
Thursday, November 16, 2023
Thursday, November 09, 2023
Thursday, November 02, 2023
Tuesday, September 19, 2023
Thursday, August 31, 2023
Tuesday, August 29, 2023
- Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
- Inhibrx Announces $200M Private Placement Financing; In The PIPE, Co Is Selling An Aggregate Of 3,621,314 Shares Of Its Common Stock At A Price Of $19.35 Per Share
